Does EVEROLIMUS Cause Metastases to bone? 845 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 845 reports of Metastases to bone have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 2.1% of all adverse event reports for EVEROLIMUS.
845
Reports of Metastases to bone with EVEROLIMUS
2.1%
of all EVEROLIMUS reports
140
Deaths
173
Hospitalizations
How Dangerous Is Metastases to bone From EVEROLIMUS?
Of the 845 reports, 140 (16.6%) resulted in death, 173 (20.5%) required hospitalization, and 21 (2.5%) were considered life-threatening.
Is Metastases to bone Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 845 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Metastases to bone?
LETROZOLE (1,735)
RIBOCICLIB (1,538)
FULVESTRANT (1,525)
ZOLEDRONIC ACID (1,087)
DENOSUMAB (1,053)
TAMOXIFEN (894)
LEUPROLIDE (848)
PACLITAXEL (820)
PALBOCICLIB (793)
CAPECITABINE (763)
Which EVEROLIMUS Alternatives Have Lower Metastases to bone Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE